Are There New Approaches in Lower Risk MDS? Overview of Lenalidomide and Luspatercept Trials, Hypomethylating Agents & Spliceosomal Mutations
By
Indy Hematology Review
FEATURING
Richard Stone
By
Indy Hematology Review
FEATURING
Richard Stone
Login to view comments.
Click here to Login